Inventiva secures new patent in the US strengthening the protection of its lead product candidate lanifibranor

    NEXT STORY
    Air Methods Celebrates ARCH Air Medical’s 40th Year of Dedication to the St. Louis Area
    PREV STORY
    Genkyotex Extends Conversion Period for Outstanding €1.6 Million Convertible Debt by 12 Months
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

    author_avatar
    NASDAQ Market News

    Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma

    author_avatar
    NASDAQ Market News

    Curetis To Attend Key Conferences in the Fourth Quarter of 2019

    author_avatar
    NASDAQ Market News